ANPEP and neoplasm: Given the potential of DR and CD13 inhibition, the current study demonstrated a novel molecular mechanism through which inhibition of CD13 facilitates tumor cell sensitization to TRAIL/DR4-induced cell death, thus extending understanding of the extrinsic cytotoxic pathway in tumor cells and providing a new strategy for TRAIL-based treatment.